Price Change Distribution, Measured at the Drug Level | 2013-2014 | |||
---|---|---|---|---|
Overall | % > Medical CPI | % > 15% | % > 20% | |
Number of Unique Molecules in Sample | 2,285 | 1,648 | 987 | 826 |
Molecule-Seller-Formulation Combinations in Sample | 6,182 | 3,102 | 1,713 | 1,425 |
Percentage of Molecule-Seller-Formulation Combinations Meeting Threshold | - | 50% | 28% | 13% |
Number of Manufacturers in Sample | 378 | 319 | 213 | 197 |
Percentage of total manufacturers producing molecules meeting threshold | - | 84% | 56% | 52% |
Quarterly Use (millions of units) | ||||
Mean | 7.83 | 7.03 | 7.49 | 7.94 |
Standard Deviation | 3.48 | 3.67 | 2.62 | 2.76 |
Quarterly Sales (millions of dollars) | ||||
Average | 3.66 | 3.78 | 3.53 | 2.83 |
Standard Deviation | 1.73 | 2.01 | 1.71 | 1.13 |
Price Change | ||||
Mean | 38% | 93% | 162% | 191% |
Median | 2% | 17% | 41% | 52% |
95th Percentile | 135% | 249% | 376% | 424% |
Standard Deviation | 1053% | 1485% | 1995% | 2187% |
Price Level, 2013 ($) | ||||
Average | 29.69 | 43.35 | 30.72 | 22.63 |
Standard Deviation | 378.44 | 521.16 | 385.12 | 292.56 |
Hot Spot Market Shareb | ||||
Based on Total Extended Units Sold | - | 45% | 27% | 23% |
Based on Total Inflation-Adjusted Sales | - | 25% | 12% | 8% |